Home / Inspections / 1196992

FDA Inspection 1196992 — Carter BloodCare - Irving

Carter BloodCare - Irving — FEI 3003103575

The FDA completed an inspection of Carter BloodCare - Irving on February 9, 2023 in Irving, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
February 9, 2023
Fiscal Year
2023
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Irving, TX (United States)

Facility

Other inspections at this facility

  • 1264281 (NAI Thu Mar 13 2025 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1067145 (NAI Tue Aug 28 2018 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 964991 (NAI Wed Mar 23 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 864912 (NAI Wed Feb 05 2014 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 761809 (NAI Wed Jan 04 2012 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources